Sign up USA
Proactive Investors - Run By Investors For Investors

Tilray raises $435 million via convertible debt offering

A portion of the money raised will go to paying off the $9.1 million existing mortgage on its facility in British Columbia
Marijuana leaves
The Canadian company distributes medical cannabis in 12 countries

Tilray Inc (NASDAQ:TLRY) shares dipped following the close of its convertible debt offering.

The cannabis company announced last week that it would offer $450 million worth of convertible senior notes due in 2023 in a private placement to qualified institutional buyers.

READ: Tilray acquires Alef Biotechnology to expand cannabis presence in Latin America

After expenses, the company raised a total of $435 million. The initial offer was worth $400 million, but was later upsized.

The 5.00% notes will be convertible into cash, shares of its Class 2 common stock, or a combination of the two.

The proceeds will go towards working capital, acquisitions and corporate expenses as well as paying off the $9.1 million existing mortgage on its facility in British Columbia.

The Canadian cannabis company cultivates and distributes medical cannabis to 12 countries, including Canada, Australia, New Zealand and Germany.

Shares of Tilray were down more than 4% to $130.94 in Thursday pre-market trading.


Contact Lenore Fedow at [email protected]

Follow her on Twitter@LenoreMariee


Join our Crypto, Blockchain and Cannabis Telegram group here
View full TLRY profile View Profile

Tilray Inc Timeline

Related Articles

August 28 2018
Tidal Royalty provides capital to help grow licenced US cannabis firms in exchange for receiving a percentage of future top-line revenues.
Management behind ICC International Cannabis Corp has a clear buy, build and sell strategy

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You understand that the Company receives either monetary or securities compensation for our services. We stand to benefit from any volume this write-up may generate.

You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Copyright ©, 2018. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use